Picture of Memscap SA logo

MEMS — Memscap SA News Story

0.000.00%
fr flag iconLast trade - 00:00
TechnologySpeculativeMicro CapHigh Flyer

France's MEMSCAP Q2 revenue rises on aerospace and medical strength

France's MEMSCAP Q2 revenue rises on aerospace and medical strength


Overview

  • France pressure sensor maker's Q2 revenue rose 19.9% yr/yr, driven by aerospace and medical growth

  • Q2 adjusted EBITDA and net profit rose sharply, reflecting improved profitability

  • Gross margin improved from Q1 but was lower yr/yr due to foreign exchange effects


Outlook

  • MEMSCAP expects ramp-up of Engine Control and Fluidic Systems to broaden revenue base

  • Company says macroeconomic uncertainty and FX volatility remain factors for future performance


Result Drivers

  • AEROSPACE DEMAND - Co said aerospace business remained largest contributor, supported by continued robust demand

  • MEDICAL SEGMENT GROWTH - Co said medical segment revenue rose 78.8% yr/yr, driven by sustained demand in invasive blood pressure monitoring

  • OPTICAL COMMUNICATIONS DELAYS - Co said optical communications revenue fell yr/yr due to temporary shipment delays from industrial transition and qualification activities


Company press release: ID:nBw2kWZlXa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Net Income

EUR 442,000

Q2 Adjusted EBITDA

EUR 643,000

Q2 Gross Margin

40.00%

Q2 Operating Expenses

EUR 1.12 mln

Q2 Revenue

EUR 3.64 mln


Analyst Coverage

  • The one available analyst rating on the shares is "strong buy"

  • The average consensus recommendation for the semiconductors peer group is "buy."

  • Wall Street's median 12-month price target for Memscap SA is €6.00, about 26.8% above its July 27 closing price of €4.73

  • The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 19 three months ago


Reuters Recommended Reads

  • July 28 - Jet engine maker Safran raises targets after record first-half margin

  • July 28 - UK's Bodycote H1 revenue rises on aerospace demand

  • July 28 - France's Novacyt H1 revenue rises on SCD acquisition


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Memscap SA

See all news